You have 9 free searches left this month | for more free features.

adult acute myeloid leukemia with t(8;21)(q22;q22)

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Stanford, California
  • +3 more
May 2, 2019

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +14 more
  • Stanford, California
    Stanford University Cancer Institute
Apr 1, 2019

Bone Marrow and Blood Samples in Untreated Acute Myeloid

Completed
  • Leukemia
  • laboratory biomarker analysis
  • San Diego, California
  • +45 more
Aug 2, 2022

Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic

Completed
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +115 more
  • Fludarabine Phosphate
  • +6 more
  • Denver, Colorado
  • +10 more
Oct 29, 2019

Tissue and Blood Samples From Acute Myeloid Leukemia

Active, not recruiting
  • Leukemia
  • DNA analysis
  • +7 more
  • Mountain View, California
  • +76 more
Aug 2, 2022

Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • Fludarabine and Busulfan
  • Fludarabine and Melphalan
  • Wuhan, Hubei, China
    Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
Jan 5, 2023

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +17 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 27, 2019

Core Binding Factor Acute Myeloid Leukemia Trial in Guangzhou (Sorafenib, Idarubicin, Cytarabine)

Recruiting
  • Core Binding Factor Acute Myeloid Leukemia
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
May 31, 2022

Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid

Completed
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
  • +33 more
  • therapeutic allogeneic lymphocytes
  • Stanford, California
    Stanford University
Mar 16, 2019

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • metformin hydrochloride
  • +2 more
  • Chicago, Illinois
    Northwestern University
Jan 8, 2019

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +19 more
  • umbilical cord blood transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 27, 2019

Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid

Completed
  • Adult Acute Erythroid Leukemia (M6)
  • +15 more
  • liposomal cytarabine-daunorubicin CPX-351
  • Stanford, California
    Stanford University, School of Medicine
Jan 17, 2019

Leukemia Trial (biological, drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • aldesleukin
  • +9 more
  • (no location specified)
Feb 17, 2022

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • sargramostim
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2022

Frequency and Risk Factors of Acute Myeloid Leukemia

Not yet recruiting
  • Myeloid Leukemia
  • Bone marrow aspirite for diagnosis
  • (no location specified)
Mar 15, 2023

Multidrug Resistance Genes in Acute Myeloid Leukemia

Active, not recruiting
  • Leukemia
  • gene expression analysis
  • +4 more
  • Fort Wayne, Indiana
    Fort Wayne Medical Oncology and Hematology
Aug 16, 2021

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Terminated
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +14 more
  • Stanford, California
    Stanford University, School of Medicine
Oct 25, 2018

Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)

Active, not recruiting
  • Leukemia
  • Birmingham, Alabama
  • +184 more
Feb 4, 2022

Leukemia Trial in United States (arsenic trioxide, gemtuzumab ozogamicin, mercaptopurine)

Completed
  • Leukemia
  • arsenic trioxide
  • +4 more
  • Roseville, California
  • +191 more
Dec 14, 2022

Leukemia, MDS Trial in Duarte (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • fludarabine phosphate
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults, AML (Adult) With 11q23

Terminated
  • Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults
  • +7 more
  • Stanford, California
    Stanford University School of Medicine
Sep 25, 2018

Leukemia, MDS Trial (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Feb 17, 2022

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

Recruiting
  • Brain and Central Nervous System Tumors
  • +8 more
  • 3'-deoxy-3'-[18F]fluorothymidine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Mar 30, 2022

B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent

Terminated
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1
  • +4 more
  • Chicago, Illinois
    Northwestern University
Jan 31, 2020

Diagnostic Yield Among M-FISH, FISH Probe Panel and Conventional

Completed
  • Acute Myeloid Leukemia
  • Conventional Cytogenetics Studies
  • +2 more
  • Assiut, Egypt
    South Egypt Cancer Institute
Mar 7, 2022